Point72 Hong Kong Ltd - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 77 filers reported holding RELMADA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$15,000
+650.0%
773
+1580.4%
0.00%
Q2 2020$2,000460.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
VR Adviser, LLC 853,206$30,041,0003.26%
COMMODORE CAPITAL LP 161,565$5,689,0002.27%
TANG CAPITAL MANAGEMENT LLC 200,000$7,042,0001.98%
PARSONS CAPITAL MANAGEMENT INC/RI 451,412$15,894,0001.30%
Avoro Capital Advisors LLC 1,525,000$53,695,0000.93%
RTW INVESTMENTS, LP 1,530,717$53,897,0000.84%
Pegasus Asset Management, Inc. 26,958$949,0000.48%
COWEN AND COMPANY, LLC 166,942$5,878,0000.40%
Ikarian Capital, LLC 290,207$10,218,0000.34%
Spotlight Asset Group, Inc. 24,565$865,0000.32%
View complete list of RELMADA THERAPEUTICS INC shareholders